Figure Legends from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with PembrolizumabRichard W. Joseph, Tara C. Gangadhar, Jeroen Elassaiss‐Schaap et al.|Unknown|2023Cited by 0
Table S1 from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with PembrolizumabRichard W. Joseph, Tara C. Gangadhar, Jeroen Elassaiss‐Schaap et al.|Unknown|2023Cited by 0
Table S2 from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with PembrolizumabRichard W. Joseph, Tara C. Gangadhar, Jeroen Elassaiss‐Schaap et al.|Unknown|2023Cited by 0
Figure S1 from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with PembrolizumabRichard W. Joseph, Tara C. Gangadhar, Jeroen Elassaiss‐Schaap et al.|Unknown|2023Cited by 0
Figure S2 from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with PembrolizumabRichard W. Joseph, Tara C. Gangadhar, Jeroen Elassaiss‐Schaap et al.|Unknown|2023Cited by 0